Claritev Corp, a healthcare cost management technology provider, reported a positive turnaround in operating income for fiscal year 2025 after steep losses in 2024. The company’s revenue grew modestly by 3.7%, driven by its claims intelligence, network solutions, and new international partnerships in the MENA region. However, net income remains deeply negative due to substantial interest expenses and prior goodwill impairments. Liquidity is supported by conservative borrowing under a revolving credit facility and cash from operations, but Claritev faces ongoing risks from high client concentration, competitive pricing pressures, complex litigation exposure, and evolving regulatory frameworks. Its multi-year technology transformation initiatives increase operating leverage and costs short term but may underpin future scalability.